219 related articles for article (PubMed ID: 17363064)
1. Activity-dependent neuroprotective protein: from gene to drug candidate.
Gozes I
Pharmacol Ther; 2007 May; 114(2):146-54. PubMed ID: 17363064
[TBL] [Abstract][Full Text] [Related]
2. NAP, a peptide derived from the activity-dependent neuroprotective protein, modulates macrophage function.
Quintana FJ; Zaltzman R; Fernandez-Montesinos R; Herrera JL; Gozes I; Cohen IR; Pozo D
Ann N Y Acad Sci; 2006 Jul; 1070():500-6. PubMed ID: 16888216
[TBL] [Abstract][Full Text] [Related]
3. Activity-dependent neuroprotective protein snippet NAP reduces tau hyperphosphorylation and enhances learning in a novel transgenic mouse model.
Vulih-Shultzman I; Pinhasov A; Mandel S; Grigoriadis N; Touloumi O; Pittel Z; Gozes I
J Pharmacol Exp Ther; 2007 Nov; 323(2):438-49. PubMed ID: 17720885
[TBL] [Abstract][Full Text] [Related]
4. The influence of the peptide NAP on Mac-1-deficient mice following closed head injury.
Zaltzman R; Alexandrovich A; Trembovler V; Shohami E; Gozes I
Peptides; 2005 Aug; 26(8):1520-7. PubMed ID: 16042992
[TBL] [Abstract][Full Text] [Related]
5. The expression of activity-dependent neuroprotective protein (ADNP) is regulated by brain damage and treatment of mice with the ADNP derived peptide, NAP, reduces the severity of traumatic head injury.
Gozes I; Zaltzman R; Hauser J; Brenneman DE; Shohami E; Hill JM
Curr Alzheimer Res; 2005 Apr; 2(2):149-53. PubMed ID: 15974912
[TBL] [Abstract][Full Text] [Related]
6. Microtubules, schizophrenia and cognitive behavior: preclinical development of davunetide (NAP) as a peptide-drug candidate.
Gozes I
Peptides; 2011 Feb; 32(2):428-31. PubMed ID: 21050875
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective effects of NAP against excitotoxic brain damage in the newborn mice: implications for cerebral palsy.
Sokolowska P; Passemard S; Mok A; Schwendimann L; Gozes I; Gressens P
Neuroscience; 2011 Jan; 173():156-68. PubMed ID: 21073926
[TBL] [Abstract][Full Text] [Related]
8. Recombinant activity-dependent neuroprotective protein protects cells against oxidative stress.
Steingart RA; Gozes I
Mol Cell Endocrinol; 2006 Jun; 252(1-2):148-53. PubMed ID: 16704895
[TBL] [Abstract][Full Text] [Related]
9. Sexual dimorphism of activity-dependent neuroprotective protein in the mouse arcuate nucleus.
Furman S; Hill JM; Vulih I; Zaltzman R; Hauser JM; Brenneman DE; Gozes I
Neurosci Lett; 2005 Jan; 373(1):73-8. PubMed ID: 15555780
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective effect of the peptides ADNF-9 and NAP on hypoxic-ischemic brain injury in neonatal rats.
Kumral A; Yesilirmak DC; Sonmez U; Baskin H; Tugyan K; Yilmaz O; Genc S; Gokmen N; Genc K; Duman N; Ozkan H
Brain Res; 2006 Oct; 1115(1):169-78. PubMed ID: 16938277
[TBL] [Abstract][Full Text] [Related]
11. Differential regulation of activity-dependent neuroprotective protein in rat astrocytes by VIP and PACAP.
Zusev M; Gozes I
Regul Pept; 2004 Dec; 123(1-3):33-41. PubMed ID: 15518891
[TBL] [Abstract][Full Text] [Related]
12. The cytoskeleton as a drug target for neuroprotection: the case of the autism- mutated ADNP.
Gozes I
Biol Chem; 2016 Mar; 397(3):177-84. PubMed ID: 25955282
[TBL] [Abstract][Full Text] [Related]
13. Protection against tauopathy by the drug candidates NAP (davunetide) and D-SAL: biochemical, cellular and behavioral aspects.
Shiryaev N; Pikman R; Giladi E; Gozes I
Curr Pharm Des; 2011; 17(25):2603-12. PubMed ID: 21728979
[TBL] [Abstract][Full Text] [Related]
14. Novel tubulin and tau neuroprotective fragments sharing structural similarities with the drug candidate NAP (Davuentide).
Gozes I; Iram T; Maryanovsky E; Arviv C; Rozenberg L; Schirer Y; Giladi E; Furman-Assaf S
J Alzheimers Dis; 2014; 40 Suppl 1():S23-36. PubMed ID: 24503616
[TBL] [Abstract][Full Text] [Related]
15. From vasoactive intestinal peptide (VIP) through activity-dependent neuroprotective protein (ADNP) to NAP: a view of neuroprotection and cell division.
Gozes I; Divinsky I; Pilzer I; Fridkin M; Brenneman DE; Spier AD
J Mol Neurosci; 2003; 20(3):315-22. PubMed ID: 14501014
[TBL] [Abstract][Full Text] [Related]
16. Activity-dependent neuroprotective protein (ADNP) expression level is correlated with the expression of the sister protein ADNP2: deregulation in schizophrenia.
Dresner E; Agam G; Gozes I
Eur Neuropsychopharmacol; 2011 May; 21(5):355-61. PubMed ID: 20598862
[TBL] [Abstract][Full Text] [Related]
17. Brain deficits associated with fetal alcohol exposure may be protected, in part, by peptides derived from activity-dependent neurotrophic factor and activity-dependent neuroprotective protein.
Sari Y; Gozes I
Brain Res Rev; 2006 Aug; 52(1):107-18. PubMed ID: 16488478
[TBL] [Abstract][Full Text] [Related]
18. The autism/neuroprotection-linked ADNP/NAP regulate the excitatory glutamatergic synapse.
Sragovich S; Malishkevich A; Piontkewitz Y; Giladi E; Touloumi O; Lagoudaki R; Grigoriadis N; Gozes I
Transl Psychiatry; 2019 Jan; 9(1):2. PubMed ID: 30664622
[TBL] [Abstract][Full Text] [Related]
19. A peptide derived from activity-dependent neuroprotective protein (ADNP) ameliorates injury response in closed head injury in mice.
Beni-Adani L; Gozes I; Cohen Y; Assaf Y; Steingart RA; Brenneman DE; Eizenberg O; Trembolver V; Shohami E
J Pharmacol Exp Ther; 2001 Jan; 296(1):57-63. PubMed ID: 11123362
[TBL] [Abstract][Full Text] [Related]
20. A novel VIP responsive gene. Activity dependent neuroprotective protein.
Gozes I; Zamostiano R; Pinhasov A; Bassan M; Giladi E; Steingart RA; Brenneman DE
Ann N Y Acad Sci; 2000; 921():115-8. PubMed ID: 11193814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
